financetom
Business
financetom
/
Business
/
Bombardier to Confirm 2025 Objectives, Detail Growth Levers Through 2030 as Part of Investor Day
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Bombardier to Confirm 2025 Objectives, Detail Growth Levers Through 2030 as Part of Investor Day
May 1, 2024 5:09 AM

07:51 AM EDT, 05/01/2024 (MT Newswires) -- Bombardier (BBD-B.TO) said on Wednesday that it will host its investor day on May 1 during which executives will review the company's performance over the past three years and look at how 2025 commitments will be met.

Chief Executive Eric Martel and Chief Financial Officer Bart Demosky will be joined at the company's aircraft assembly centre at Pearson Airport in Toronto by members of Bombardier's executive leadership team. The group will outline the company's progress on several fronts, including the expansion of Bombardier Defense and growth in services. They will also provide an update on how the company has positioned itself for growth through 2030.

"Bombardier is well on track to meet its 2025 objectives thanks to everyone's collective focus on executing our plan flexibly, creatively and passionately," said Martel in a statement.

According to the statement, Bombardier is on a path to achieve its stated 2025 objectives of more than $9 billion in revenues and more than $1.625 billion in adjusted EBITDA.

Separately, Bombardier on Wednesday said that its client NetJets has been revealed as the previously confidential buyer of 12 Challenger 3500 aircraft. The transaction, initially announced in December 2023, was valued at US$326.4 million based on list prices at the time of signing, but the landmark deal could be more than US$6 billion if all optional 232 Challenger 3500 jets are exercised over time. Deliveries for aircraft included in the firm order are set to begin in the second half of 2025.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Range Resources Q4 Adjusted Earnings Rise, Revenue Declines
Range Resources Q4 Adjusted Earnings Rise, Revenue Declines
Feb 25, 2025
05:15 PM EST, 02/25/2025 (MT Newswires) -- Range Resources ( RRC ) late Tuesday reported Q4 adjusted net income of $0.68 per diluted share, up from $0.63 a year earlier. Analysts polled by FactSet expected $0.61. Revenue for the quarter ended Dec. 31 was $626.4 million, down from $941.5 million a year earlier. Analysts surveyed by FactSet expected $691.1 million....
AMC tops revenue target as box office hits drive strong demand
AMC tops revenue target as box office hits drive strong demand
Feb 25, 2025
Feb 25 (Reuters) - AMC Entertainment ( AMC ) topped Wall Street estimates for quarterly revenue on Tuesday, boosted by wildly popular releases including Moana 2 and Wicked that helped draw a strong crowd of moviegoers. Shares of the company rose about 3% in extended trading after it reported a 20% jump in attendance in theaters in the fourth quarter....
Vaxcyte 2024 Loss Narrows
Vaxcyte 2024 Loss Narrows
Feb 25, 2025
05:20 PM EST, 02/25/2025 (MT Newswires) -- Vaxcyte ( PCVX ) reported a full-year 2024 net loss late Tuesday of $3.80 per diluted share, narrower than a per-share loss of $4.14 a year earlier. Analysts polled by FactSet expected a per-share loss of $3.91. The company said it had cash, cash equivalents and investments of $3.13 billion as of Dec....
Boehringer Ingelheim wins trial in two Zantac lawsuits
Boehringer Ingelheim wins trial in two Zantac lawsuits
Feb 25, 2025
Feb 25 (Reuters) - Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung juries. A state court jury in Chicago on Monday found in favor of the privately held German drugmaker following a joint trial of individual cases brought by Chicago residents...
Copyright 2023-2026 - www.financetom.com All Rights Reserved